Serum Thioredoxin-80 is associated with age, ApoE4, and neuropathological biomarkers in Alzheimer’s disease: a potential early sign of AD
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum Thioredoxin-80 is associated with age, ApoE4, and neuropathological biomarkers in Alzheimer’s disease: a potential early sign of AD
Authors
Keywords
-
Journal
Alzheimers Research & Therapy
Volume 14, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-25
DOI
10.1186/s13195-022-00979-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of APOE Genotype With Heterogeneity of Cognitive Decline Rate in Alzheimer Disease
- (2021) Jing Qian et al. NEUROLOGY
- Alzheimer’s Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways
- (2020) Na Zhao et al. NEURON
- The Important Interface Between Apolipoprotein E and Neuroinflammation in Alzheimer’s Disease
- (2020) Courtney M. Kloske et al. Frontiers in Immunology
- Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment
- (2019) Raúl Loera-Valencia et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker
- (2019) Patricia Regina Manzine et al. BIOMEDICINE & PHARMACOTHERAPY
- Understanding the Role of Systemic Inflammation in Alzheimer’s Disease
- (2019) Keenan A. Walker et al. ACS Chemical Neuroscience
- Brain volumes and cortical thickness on MRI in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)
- (2019) Ruth Stephen et al. Alzheimers Research & Therapy
- Thioredoxin-80 protects against amyloid-beta pathology through autophagic-lysosomal pathway regulation
- (2019) Gorka Gerenu et al. MOLECULAR PSYCHIATRY
- Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid
- (2019) Anna Rosenberg et al. Alzheimers Research & Therapy
- Targeting Alzheimer's disease with gene and cell therapies
- (2018) R. Loera-Valencia et al. JOURNAL OF INTERNAL MEDICINE
- APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types
- (2018) Yuan-Ta Lin et al. NEURON
- Biomarkers for Alzheimer's disease: current status and prospects for the future
- (2018) K. Blennow et al. JOURNAL OF INTERNAL MEDICINE
- Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
- (2018) Luigi Ferrucci et al. Nature Reviews Cardiology
- Associations of CAIDE Dementia Risk Score with MRI, PIB-PET measures, and cognition
- (2017) Ruth Stephen et al. JOURNAL OF ALZHEIMERS DISEASE
- The role of APOE on lipid homeostasis and inflammation in normal brains
- (2017) G. William Rebeck JOURNAL OF LIPID RESEARCH
- ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
- (2017) Yang Shi et al. NATURE
- Midlife systemic inflammatory markers are associated with late-life brain volume
- (2017) Keenan A. Walker et al. NEUROLOGY
- Brain amyloid load and its associations with cognition and vascular risk factors in FINGER Study
- (2017) Nina Kemppainen et al. NEUROLOGY
- ApoE4 Accelerates Early Seeding of Amyloid Pathology
- (2017) Chia-Chen Liu et al. NEURON
- sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
- (2016) Marc Suárez‐Calvet et al. EMBO Molecular Medicine
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- Differential diagnosis of neurodegenerative diseases using structural MRI data
- (2016) Juha Koikkalainen et al. NeuroImage-Clinical
- Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings
- (2015) Clifford R. Jack et al. BRAIN
- A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial
- (2015) Tiia Ngandu et al. LANCET
- APOE ε4: The most prevalent yet understudied risk factor for Alzheimer's disease
- (2014) Daniel M. Michaelson Alzheimers & Dementia
- ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners?
- (2014) Takahisa Kanekiyo et al. NEURON
- Recruitment and Baseline Characteristics of Participants in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)—A Randomized Controlled Lifestyle Trial
- (2014) Tiia Ngandu et al. International Journal of Environmental Research and Public Health
- The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): Study design and progress
- (2013) Miia Kivipelto et al. Alzheimers & Dementia
- Truncated thioredoxin (Trx-80) promotes pro-inflammatory macrophages of the M1 phenotype and enhances atherosclerosis
- (2013) Dler Faieeq Darweesh Mahmood et al. JOURNAL OF CELLULAR PHYSIOLOGY
- ADAM10 in Synaptic Physiology and Pathology
- (2013) Stefano Musardo et al. Neurodegenerative Diseases
- Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
- (2013) D. M. Holtzman et al. Cold Spring Harbor Perspectives in Medicine
- Thioredoxin-80 is a product of alpha-secretase cleavage that inhibits amyloid-beta aggregation and is decreased in Alzheimer's disease brain
- (2012) Francisco Gil-Bea et al. EMBO Molecular Medicine
- Multi-stage segmentation of white matter hyperintensity, cortical and lacunar infarcts
- (2012) Yanbo Wang et al. NEUROIMAGE
- Thioredoxin 80-Activated-Monocytes (TAMs) Inhibit the Replication of Intracellular Pathogens
- (2011) Ximena Cortes-Bratti et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started